Skip to content

Multimodal Pulmonary Rehabilitation in Radiographic Axial Spondyloarthritis

Multimodal Pulmonary Rehabilitation in Radiographic Axial Spondyloarthritis: A Prospective Pilot Study Addressing Mechanical Restriction and Functional Capacity

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07430189
Acronym
PuRe-axSpA
Enrollment
20
Registered
2026-02-24
Start date
2018-05-30
Completion date
2020-09-30
Last updated
2026-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axial Spondyloarthritis (AxSpA)

Keywords

Pulmonary Rehabilitation, Exercise Tolerance, Dyspnea, Spirometry, Restrictive Lung Disease

Brief summary

This prospective pilot study aims to evaluate the efficacy of a structured 8-week multimodal pulmonary rehabilitation (PR) program specifically designed for patients with radiographic axial spondyloarthritis (r-axSpA). The study assesses the impact of a composite intervention incorporating aerobic conditioning, resistance training, flexibility protocols, and targeted diaphragmatic breathing on functional exercise capacity, dyspnea severity, and pulmonary function.

Interventions

An 8-week structured exercise program consisting of three sessions per week (two supervised hospital-based sessions and one structured home-based session). The intervention integrates aerobic conditioning using a treadmill and arm ergometer, resistance and mobility training targeting spinal extension, and specific respiratory muscle training including diaphragmatic and pursed-lip breathing maneuvers.

Sponsors

Balikesir University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

A prospective, single-arm, open-label pilot study to evaluate the feasibility and efficacy of multimodal pulmonary rehabilitation.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 75 years. * Diagnosis of radiographic axial spondyloarthritis (r-axSpA) confirmed according to the Modified New York Criteria. * Clinical stability without acute flares or escalation of systemic therapy in the preceding 3 months. * Ability to perform spirometry and ambulate safely.

Exclusion criteria

* Primary respiratory disorders (e.g., COPD and interstitial lung disease) acting as the primary cause of limitation. * Significant cardiovascular contraindications to exercise. * Pregnancy. * Participation in a structured rehabilitation program within the last 3 months.

Design outcomes

Primary

MeasureTime frameDescription
Change in 6-Minute Walk Distance (6MWD)Baseline and Week 8Functional exercise capacity is measured by the total distance walked in 6 minutes, recorded in meters. Higher values indicate better functional exercise capacity (better outcome).

Secondary

MeasureTime frameDescription
Change in Borg Dyspnea ScaleBaseline and Week 8The Modified Borg Dyspnea Scale is used to assess exertional breathlessness. The scale ranges from a minimum of 0 (no dyspnea at all) to a maximum of 10 (maximal dyspnea). Higher scores indicate more severe breathlessness (worse outcome).
Change in Forced Vital Capacity (FVC)Baseline and Week 8Forced Vital Capacity (FVC) is measured via spirometry and expressed as a percentage of the predicted value. Higher percentages indicate better pulmonary volume and respiratory function (better outcome).
Change in BASFI ScoreBaseline and Week 8The Bath Ankylosing Spondylitis Functional Index (BASFI) assesses the degree of functional limitation in daily activities. The scale ranges from a minimum of 0 to a maximum of 10. Higher scores indicate greater functional impairment and disability (worse outcome).
Change in SF-36 Mental Health ScoreBaseline and Week 8The 36-Item Short Form Health Survey (SF-36) is a health-related quality of life questionnaire. The Mental Health domain is scored from a minimum of 0 to a maximum of 100. Higher scores indicate a more favorable mental health state and better well-being (better outcome).

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026